Skip to main content

previous disabled Page of 4
and
  1. Article

    Open Access

    Acute lymphoblastic leukemia relapsing after first-line pediatric-inspired therapy: a retrospective GRAALL study

    The outcome of adult patients with Philadelphia chromosome-negative acute lymphoblastic leukemia (Ph− ALL) relapsing after pediatric-inspired front-line therapy is ill known. Here 229 relapsing Ph− ALL younger...

    A Desjonquères, P Chevallier, X Thomas, F Huguet, T Leguay in Blood Cancer Journal (2016)

  2. Article

    Open Access

    Clinical, pharmacokinetic and pharmacodynamic data for the MEK1/2 inhibitor pimasertib in patients with advanced hematologic malignancies

    F Ravandi, A Pigneux, D J DeAngelo, E Raffoux, J Delaunay, X Thomas in Blood Cancer Journal (2015)

  3. No Access

    Article

    Early death in acute promyelocytic leukemia (APL) in French centers: a multicenter study in 399 patients

    R Rahmé, X Thomas, C Recher, N Vey, J Delaunay, E Deconinck, P Hirsch in Leukemia (2014)

  4. No Access

    Article

    Impact of raw pig slurry and pig farming practices on physicochemical parameters and on atmospheric N2O and CH4 emissions of tropical soils, Uvéa Island (South Pacific)

    Emissions of CH4 and N2O related to private pig farming under a tropical climate in Uvéa Island were studied in this paper. Physicochemical soil parameters such as nitrate, nitrite, ammonium, Kjeldahl nitrogen, t...

    E. Roth, P. Gunkel-Grillon, L. Joly in Environmental Science and Pollution Resear… (2014)

  5. No Access

    Article

    High burden of BK virus-associated hemorrhagic cystitis in patients undergoing allogeneic hematopoietic stem cell transplantation

    BK virus (BKV) reactivation has been increasingly associated with the occurrence of late-onset hemorrhagic cystitis (HC) after allogeneic hematopoietic SCT (allo-HSCT) resulting in morbidity and sometimes mort...

    L Gilis, S Morisset, G Billaud, S Ducastelle-Leprêtre in Bone Marrow Transplantation (2014)

  6. No Access

    Article

    Evaluation of allogeneic hematopoietic SCT in younger adults with adverse karyotype AML

    To illustrate methodological issues, we compared donor vs no-donor to transplant vs no-transplant comparisons in a cohort of 107 patients aged ⩽50 years with adverse karyotype AML in first CR. Adverse karyotyp...

    M A Hospital, X Thomas, S Castaigne, E Raffoux, C Pautas in Bone Marrow Transplantation (2012)

  7. No Access

    Article

    Invasive aspergillosis: an important risk factor on the short- and long-term survival of acute myeloid leukemia (AML) patients

    Invasive aspergillosis (IA) during induction chemotherapy of acute myeloid leukemia (AML) could worsen the prognosis. Our objective was to study how the development of IA during AML interferes with the therape...

    M. Michallet, T. Bénet, M. Sobh, S. Kraghel in European Journal of Clinical Microbiology … (2012)

  8. No Access

    Article

    Prognostic significance of DNA methyltransferase 3A mutations in cytogenetically normal acute myeloid leukemia: a study by the Acute Leukemia French Association

    Recently, DNA methyltransferase 3A (DNMT3A) mutations have been identified in acute myeloid leukemia (AML), the highest frequency being found within cytogenetically normal (CN) AML. In this study, diagnostic samp...

    A Renneville, N Boissel, O Nibourel, C Berthon, N Helevaut, C Gardin in Leukemia (2012)

  9. No Access

    Article

    Wilms' tumor 1 single-nucleotide polymorphism rs16754 does not predict clinical outcome in adult acute myeloid leukemia

    A Renneville, N Boissel, N Helevaut, O Nibourel, C Terré, C Pautas, C Gardin in Leukemia (2011)

  10. No Access

    Article

    Development of a versatile atmospheric N2O sensor based on quantum cascade laser technology at 4.5 μm

    We report the development of a field-deployable infrared laser spectrometer using new quantum cascade laser technology at 4.5 μm. The instrument is designed to measure in situ N2O concentrations at ground level e...

    L. Joly, T. Decarpenterie, N. Dumelié, X. Thomas, I. Mappe-Fogaing in Applied Physics B (2011)

  11. No Access

    Article

    Another pedigree with familial acute myeloid leukemia and germline CEBPA mutation

    A Renneville, V Mialou, N Philippe, S Kagialis-Girard, V Biggio, M-T Zabot in Leukemia (2009)

  12. No Access

    Article

    Is there a role for all-trans retinoic acid in combination with recombinant erythropoetin in myelodysplastic syndromes? A report on 59 cases

    Erythropoiesis-stimulating agents (ESAs) remain the first-line treatment of anemia in lower risk myelodysplastic syndromes (MDS) without 5q deletion. A preliminary report suggested that adding all-trans retinoic ...

    R Itzykson, S Ayari, D Vassilief, E Berger, B Slama, N Vey, F Suarez in Leukemia (2009)

  13. No Access

    Article

    Recurrent in-frame insertion in C/EBPα TAD2 region is a polymorphism without prognostic value in AML

    V Biggio, A Renneville, O Nibourel, N Philippe, L Terriou, C Roumier, P Amouyel in Leukemia (2008)

  14. No Access

    Article

    Outcome of treatment after first relapse in adults with acute lymphoblastic leukemia initially treated by the LALA-94 trial

    Fifty-four percent of adults with acute lymphoblastic leukemia (ALL) who entered the LALA-94 trial experienced a first relapse. We examined the outcome of these 421 adult patients. One hundred and eighty-seven...

    E Tavernier, J-M Boiron, F Huguet, K Bradstock, N Vey, T Kovacsovics in Leukemia (2007)

  15. No Access

    Article

    Effect of priming with granulocyte–macrophage colony-stimulating factor in younger adults with newly diagnosed acute myeloid leukemia: a trial by the Acute Leukemia French Association (ALFA) Group

    In a multicenter trial, 259 young adults (15–49 years) with newly diagnosed acute myeloid leukemia (AML) were first randomized to receive a timed-sequential induction regimen given either alone (135 patients) ...

    X Thomas, E Raffoux, S de Botton, C Pautas, P Arnaud, T de Revel, O Reman in Leukemia (2007)

  16. No Access

    Article

    High efficacy and safety profile of fractionated doses of Mylotarg as induction therapy in patients with relapsed acute myeloblastic leukemia: a prospective study of the alfa group

    Pivotal phase II studies in acute myeloblastic leukemia (AML) patients in first relapse have used gemtuzumab ozogamicin (GO) (Mylotarg) at a dose of 9 mg/m2 on days 1 and 14. These studies showed a 26% response r...

    A-L Taksin, O Legrand, E Raffoux, T de Revel, X Thomas, N Contentin in Leukemia (2007)

  17. No Access

    Article

    Prospective multicentric molecular study for poor prognosis fusion transcripts at diagnosis in adult B-lineage ALL patients: the LALA 94 experience

    C Picard, S Hayette, C Bilhou-Nabera, J M Cayuela, E Delabesse, N Frenoy in Leukemia (2006)

  18. No Access

    Article

    Allogeneic stem cell transplantation improves the outcome of adults with t(1;19)/E2A-PBX1 and t(4;11)/MLL-AF4 positive B-cell acute lymphoblastic leukemia: results of the prospective multicenter LALA-94 study

    Adult patients with acute lymphoblastic leukemia (ALL) and t(1;19)/E2A-PBX1 or t(4;11)/MLL-AF4 have a poor outcome. We have evaluated the impact of an intensified post-remission therapy using a high-dose chemothe...

    N Vey, X Thomas, C Picard, T Kovascovicz, C Charin, J M Cayuela, H Dombret in Leukemia (2006)

  19. No Access

    Article

    Alloreaction increases or restores CD40, CD54, and/or HLA molecule expression in acute myelogenous leukemia blasts, through secretion of inflammatory cytokines: dominant role for TNFβ, in concert with IFNγ

    We have previously reported that alloreaction can lead to activation of dendritic cells through secretion of inflammatory cytokines. Here, we addressed whether alloreaction-derived cytokines may also lead to a...

    A Eljaafari, J Van Snick, A Voisin, F Cormont, A Farre, J Bienvenu, J Bernaud in Leukemia (2006)

  20. No Access

    Article

    Non-infusional vs intravenous consolidation chemotherapy in elderly patients with acute myeloid leukemia: final results of the EORTC-GIMEMA AML-13 randomized phase III trial

    In this trial, acute myeloid leukemia patients (pts) aged 61–80 years received MICE (mitoxantrone, etoposide and cytarabine) induction chemotherapy in combination with different schedules of granulocyte colony...

    U Jehn, S Suciu, X Thomas, F Lefrère, P Muus, Z Berneman, J-P Marie, F Adamo in Leukemia (2006)

previous disabled Page of 4